Event Date/Time: Nov 20, 2002
End Date/Time: Nov 21, 2002
Many best selling brand-name drugs have lost or are about to lose patent protection. It is essential that brand-names and generics have the offensive moves and defensive plays to maximise their most lucrative – or potentially lucrative – products on the last days of patent life. Attend this EuroLegal event to gain an in-depth and up to the minute understanding of the latest strategic, legal and regulatory developments in patent life cycle management.